David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.94% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 9.22% |
| 4 | Communication Services | 7.29% |
| 5 | Financials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
PUT
Quanta Services
PWR
$93.2B
| $230K | ﹤0.01% |
+3,200
| New | +$211K |
|
3577
Thor Industries
THO
$4.14B
| $230K | ﹤0.01% |
2,475
-90,359
| -97% | -$8.47M |
|
3578
Amcor
AMCR
$22.1B
| $229K | ﹤0.01% |
3,892
+372
| +11% | +$21.2K |
|
3579
Omnicell
OMCL
$1.58B
| $229K | ﹤0.01% |
1,908
-29,357
| -94% | -$2.88M |
|
3580
PUT
Ally Financial
ALLY
$13B
| $228K | ﹤0.01% |
6,400
-156,400
| -96% | -$4.73M |
|
3581
International Paper
IP
$21.7B
| $228K | ﹤0.01% |
4,838
-40,148
| -89% | -$1.8M |
|
|
PNNT
3582
Pennant Park Investment Corp
PNNT
$246M
| $228K | ﹤0.01% |
49,512
+37,712
| +320% | +$143K |
|
|
MODV
3583
DELISTED
ModivCare
MODV
| $227K | ﹤0.01% |
+1,638
| New | +$203K |
|
3584
Idexx Laboratories
IDXX
$43.9B
| $226K | ﹤0.01% |
452
-200
| -31% | -$89.5K |
|
3585
Merchants Bancorp
MBIN
$2.49B
| $225K | ﹤0.01% |
+12,189
| New | +$202K |
|
|
ZYXI
3586
DELISTED
Zynex
ZYXI
| $225K | ﹤0.01% |
+18,370
| New | +$239K |
|
3587
Lincoln Electric
LECO
$15.4B
| $224K | ﹤0.01% |
1,926
-800
| -29% | -$87.6K |
|
|
FBMS
3588
DELISTED
The First Bancshares, Inc.
FBMS
| $224K | ﹤0.01% |
+7,240
| New | +$194K |
|
3589
Cardiff Oncology
CRDF
$76.8M
| $221K | ﹤0.01% |
+12,274
| New | +$216K |
|
3590
KALA BIO
KALA
$15.7M
| $221K | ﹤0.01% |
13
+3
| +30% | +$56.4K |
|
3591
PetMed Express
PETS
$37.7M
| $221K | ﹤0.01% |
6,908
-59,652
| -90% | -$1.84M |
|
3592
Voya Financial
VOYA
$8.94B
| $220K | ﹤0.01% |
3,736
-15,434
| -81% | -$837K |
|
3593
Copart
CPRT
$30.8B
| $219K | ﹤0.01% |
6,876
-34,900
| -84% | -$1.02M |
|
3594
Dyne Therapeutics
DYN
$4.86B
| $216K | ﹤0.01% |
+10,280
| New | +$203K |
|
3595
Caesars Entertainment
CZR
$6.05B
| $215K | ﹤0.01% |
+2,900
| New | +$182K |
|
3596
Papa John's
PZZA
$788M
| $215K | ﹤0.01% |
2,537
-82,677
| -97% | -$6.76M |
|
3597
Sturm, Ruger & Co
RGR
$615M
| $213K | ﹤0.01% |
3,271
-2,265
| -41% | -$146K |
|
|
XOMA
3598
DELISTED
Xoma
XOMA
| $213K | ﹤0.01% |
+4,816
| New | +$145K |
|
|
LMNX
3599
DELISTED
Luminex Corp
LMNX
| $213K | ﹤0.01% |
9,209
-2,857
| -24% | -$66.4K |
|
3600
Qualys
QLYS
$6.15B
| $212K | ﹤0.01% |
1,740
-31,891
| -95% | -$3.15M |
|
Similar funds
David Shaw's Q4 2020 Portfolio in Review
As of Q4 2020, David Shaw held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Snowflake worth $147M.
- David Shaw's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- David Shaw added most to Snap in Q4 2020, an estimated $362M increase.
- David Shaw's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- David Shaw fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- David Shaw opened 563 new positions and closed 477 in Q4 2020.
- David Shaw's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.